Usher syndrome type 2 caused by activation of an USH2A pseudoexon: Implications for diagnosis and therapy
暂无分享,去创建一个
J. Millán | H. Bolz | M. Claustres | S. Malcolm | A. Roux | C. Hamel | C. Blanchet | C. Vaché | T. Besnard | Pauline le Berre | G. García-García | D. Baux | L. Larrieu | C. Abadie
[1] B. Gilbert-Dussardier,et al. Four-year follow-up of diagnostic service in USH1 patients. , 2011, Investigative ophthalmology & visual science.
[2] E. Stone,et al. Frequency of Usher syndrome in two pediatric populations: Implications for genetic screening of deaf and hard of hearing children , 2010, Genetics in Medicine.
[3] M. Ugarte,et al. Present and future of antisense therapy for splicing modulation in inherited metabolic disease , 2010, Journal of Inherited Metabolic Disease.
[4] M. Claustres,et al. Nasal epithelial cells are a reliable source to study splicing variants in Usher syndrome , 2010, Human mutation.
[5] Monte Westerfield,et al. PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. , 2010, The Journal of clinical investigation.
[6] M. Claustres,et al. Ex vivo splicing assays of mutations at noncanonical positions of splice sites in USHER genes , 2010, Human mutation.
[7] E. Aller,et al. The USH2A c.2299delG mutation: dating its common origin in a Southern European population , 2010, European Journal of Human Genetics.
[8] E. Buratti,et al. Alternative splicing: role of pseudoexons in human disease and potential therapeutic strategies , 2010, The FEBS journal.
[9] G. Barratt,et al. Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA , 2009, British journal of pharmacology.
[10] C. Béroud,et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.
[11] A. Vielle,et al. Molecular and in silico analyses of the full‐length isoform of usherin identify new pathogenic alleles in Usher type II patients , 2007, Human mutation.
[12] E. Aller,et al. Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II , 2006, Journal of Medical Genetics.
[13] Ourania Horaitis,et al. The challenge of documenting mutation across the genome: The human genome variation society approach , 2004, Human mutation.
[14] C. Cremers,et al. Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. , 2004, American journal of human genetics.
[15] Christopher B. Burge,et al. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals , 2003, RECOMB '03.
[16] C. Cremers,et al. A common ancestral origin of the frequent and widespread 2299delG USH2A mutation. , 2001, American journal of human genetics.
[17] T. Rosenberg,et al. Identification of novel USH2A mutations: implications for the structure of USH2A protein , 2000, European Journal of Human Genetics.
[18] K. Steel,et al. A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and phenotypic variation. , 1999, American journal of human genetics.
[19] C. Möller,et al. Clinical diagnosis of the Usher syndromes , 1994 .
[20] C. Möller,et al. Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium. , 1994, American journal of medical genetics.